Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Depreciation & Amortization (CF) (2022 - 2023)

Bluejay Diagnostics' Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $22342.0 for Q4 2023.

  • For Q4 2023, Depreciation & Amortization (CF) fell 27.18% year-over-year to $22342.0; the TTM value through Dec 2023 reached $522516.0, up 233.67%, while the annual FY2024 figure was $75618.0, 80.25% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2023 was $22342.0 at Bluejay Diagnostics, down from $253174.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $253174.0 in Q3 2023 and bottomed at $22342.0 in Q4 2023.